Nuvista Pharma Limited ("the Company") was originally a subsidiary of Netherlands-based Organon International. The Company has been operating in Bangladesh since 1964, with a local manufacturing facility at Tongi, Dhaka.In the post-independent Bangladesh, it was incorporated as Organon (Bangladesh) Limited under Bangladesh Companies Act as a private limited company. Following the divestment of Oraganon's equity to the local management in 2006, the Company was renamed as Nuvista Pharma Limited. In 2011, the Company, through amendments to its Memorandum and Articles of Association, became a public Limited Company under the Companies Act 1994.In 2018, Beximco Pharmaceuticals Limited, a public limited company listed with Bangladesh Stock Exchanges and AIM of London Stock Exchange, acquired majority shareholdings (85.22%) in Nuvista Pharma Limited.Carrying the legacy of the quality and manufacturing excellence of Organon, the manufacturing facilities of the Company is currently producing hormones, steroids, and other general products in different dosage forms including tablets, capsules, injections, ophthalmic drops etc. The company currently employs around 1200 employees of diverse professional backgrounds including pharmacists, doctors, engineers, chemists, microbiologists, accountants, business graduates and other white-collar professionals. The Company has multiple brands enjoying market leadership in their market categories.